PMID: 9186381Jun 7, 1997Paper

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

Lancet

Abstract

Aspirin is effective in the treatment of acute myocardial infarction and in the long-term prevention of serious vascular events in survivors of stroke and myocardial infarction. There is, however, no reliable evidence on the effectiveness of early aspirin use in acute ischaemic stroke. The Chinese Acute Stroke Trial (CAST) was a large randomised, placebo-controlled trial of the effects in hospital of aspirin treatment (160 mg/day) started within 48 h of the onset of suspected acute ischaemic stroke and continued in hospital for up to 4 weeks. The primary endpoints were death from any cause during the 4-week treatment period and death or dependence at discharge, and the analyses were by intention to treat. 21,106 patients with acute ischaemic stroke were enrolled in 413 Chinese hospitals at a mean of 25 h after the onset of symptoms (10,554 aspirin, 10,552 placebo). 87% had a CT scan before randomisation. It was prospectively planned that the results would be analysed in parallel with those of the concurrent. International Stroke Trial (IST) of 20,000 patients with acute stroke from other countries. There was a significant 14% (SD 7) proportional reduction in mortality during the scheduled treatment period (343 [3.3%] deaths amo...Continue Reading

References

Dec 1, 1992·Clinical Obstetrics and Gynecology·R J Lilford
Sep 1, 1992·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Goyot
Oct 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J BamfordC Warlow
Feb 1, 1990·Stroke; a Journal of Cerebral Circulation·C Y HuangD Chin
Jun 1, 1989·Stroke; a Journal of Cerebral Circulation·J M BamfordJ Slattery
Jan 1, 1995·Journal of Clinical Epidemiology·R PetoR Gray
Mar 15, 1997·Lancet·G V Born, R Collins
Jul 1, 1997·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Z ChenL S Liu

❮ Previous
Next ❯

Citations

Oct 9, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·P K KittusamyD J McCormick
Sep 27, 2002·Statistics in Medicine·Salim Yusuf
Sep 10, 2005·Chinese Journal of Integrative Medicine·Shang-qian ZhongYin-yuan Zhong
Mar 1, 2008·The Journal of Nutrition, Health & Aging·D W HabichtM E T McMurdo
Mar 4, 2008·Journal of Physiology and Biochemistry·J JordánT Segura
Sep 9, 2011·Der Nervenarzt·P KraftC Kleinschnitz
Mar 3, 2005·Journal of Neurology·Hugh S Markus
Sep 20, 2005·Journal of Neurology·H Bart van der WorpCor J Kalkman
May 2, 2006·Journal of Neurology·Charlotte CordonnierHilde Hénon
Oct 17, 2006·Wiener medizinische Wochenschrift·Florian B Mayr, Bernd Jilma
Jul 22, 2008·Cardiovascular Drugs and Therapy·Abhimanyu Beri, Sujeeth Reddy Punnam
Aug 13, 2005·Pharmacy World & Science : PWS·Ho Hoi LukMatthew Ng
Jun 12, 2012·Journal of Thrombosis and Thrombolysis·Eric L Wallace, Susan S Smyth
Dec 21, 2000·Current Atherosclerosis Reports·P C Combremont, M Fisher
Jun 8, 2001·Current Atherosclerosis Reports·L B Goldstein
Jun 10, 2003·Current Atherosclerosis Reports·Curtis Benesch
Jul 11, 2006·Current Atherosclerosis Reports·Peter M Rothwell
May 11, 2010·Current Atherosclerosis Reports·Neelofer Shafi, Joshua M Levine
Mar 20, 2002·Current Neurology and Neuroscience Reports·G L Bernardini, E M DeShaies
Mar 20, 2002·Current Neurology and Neuroscience Reports·Eugene D Kaplan, Ralph L Sacco
Jan 10, 2013·Current Neurology and Neuroscience Reports·Ruth M Thomson, David C Anderson
Aug 27, 2002·Current Treatment Options in Cardiovascular Medicine·Hans-Christoph Diener, Peter Ringleb
Aug 7, 2001·Current Treatment Options in Neurology·Hans-Christoph Diener, Peter Ringleb
Oct 14, 2005·Current Treatment Options in Neurology·Michael J Schneck, José Biller
Nov 30, 2000·Current Treatment Options in Neurology·B P Chan, G W Albers
May 15, 2010·Molecular Neurobiology·Yan DongAlbert Cheung Hoi Yu
May 11, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Neelofer Shafi, Scott E Kasner
Jul 16, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Samuel Yip, Oscar Benavente
Jul 13, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·George A LopezOwen Samuels
Feb 6, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Sameer BansalPooja Khatri
May 17, 2013·Drugs·Rubén Casado-ArroyoAngel Lanas
Jun 18, 2005·European Journal of Radiology·W WeberD Kuehne
Mar 5, 2003·Journal of the Neurological Sciences·Thomas O Mayer, José Biller
Jan 31, 2002·The Nursing Clinics of North America·Janice Carrozzella, Edward C Jauch
Feb 13, 2001·Survey of Ophthalmology·L D McCulloughR Wityk
May 17, 2000·Thrombosis Research·R P Atkinson, C DeLemos
Jul 27, 2001·Neurologic Clinics·R Llinas, L R Caplan
Sep 3, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H C Diener
Jul 10, 2003·Lancet Neurology·Geoffrey A Donnan, Stephen M Davis
Jul 10, 2003·Lancet Neurology·Kennedy R LeesWerner Hacke
Apr 17, 2008·European Journal of Anaesthesiology. Supplement·M Cattaneo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.